Strategic Partnerships MyMeds already engages with analytics and research partners such as CareJourney and Mayo, indicating a openness to joint initiatives. This creates sales opportunities around co-developed solutions, data integrations, and joint pilots with healthcare analytics firms and influential medical centers.

Star Ratings Focus The ACE Platform targets Part C and D Star measures, addressing over 25% of overall Star Ratings. Position opportunities around value-based care enhancements, payer conversations, and hospital/clinician performance programs that reward improved Star metrics.

Digital Adherence Advantage MyMeds emphasizes real-time actionable insights, AI-driven prioritization, and digital-human care. Sales can highlight efficiency gains, reduced costs, and improved patient engagement to health systems seeking scalable adherence and outcome management tools.

Clinical Research Footprint Past collaborations with UAMS and Mayo suggest appetite for research partnerships. Opportunities exist to offer MyMeds as a platform for digital adherence studies, observational research, and clinical trials with integrated data capture.

Growth via Payer/Provider Expansion Revenue in the low millions and a lean team indicate potential for scale through enterprise deals with mid-market health systems, independent clinics, and wellness networks. Target opportunities include expanding physician-led care teams, interoperability with EHRs, and pilots with regional health plans.